PNT - POINT Biopharma Global Inc
IEX Last Trade
12.51
12.510 100.000%
Share volume: 0
Last Updated: Tue 26 Dec 2023 09:07:44 PM CET
Pharmaceutical Preparation Manufacturing :
2.74%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
39%
Profitability
8%
Dept financing
7%
Liquidity
75%
Performance
70%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-0.28%
Return on assets
0.13%
Return on sales
-195.58%
Return on invested capital
-218.45%
Total debt ratio
15.14%
Debt ratio change over timeo
-1.16%
Current Ratio
10.02%
Quick Ratio
9.92%
Cash Position Ratio
9.64%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5.68%
Return on assets
-1.77%
Return on sales
-314.62%
Return on invested capital
-104.81%
Total debt ratio
28.03%
Debt ratio change over timeo
-1.24%
Current Ratio
6.05%
Quick Ratio
5.71%
Cash Position Ratio
5.26%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.78%
Return on sales
18.11%
Return on invested capital
0%
Total debt ratio
45.94%
Debt ratio change over time
-1.44%
Current Ratio
1.6%
Quick Ratio
0.91%
Cash Position Ratio
0.23%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-112.87%
Return on assets
-111.22%
Return on sales
-40.09%
Return on invested capital
192.6%
Total debt ratio
-116.36%
Debt ratio change over time
-1.16%
Current Ratio
-7.63%
Quick Ratio
-7.53%
Cash Position Ratio
-7.34%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PNT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -0.28% | 0% | 0% | -128.45% |
| Return on assets | 0.13% | 0% | 0% | -10.97% |
| Return on sales | -195.58% | 0% | 0% | -9137.48% |
| Return on invested capital | -218.45% | 0% | 0% | -65.55% |
| Profitability | 25% | 0% | 75% | 0% |
| Total debt ratio | 15.14% | 0% | 0% | 79.49% |
| Debt ratio change over time | -1.16% | 0% | 0% | -1% |
| Dept financing | 5% | 0% | 25% | 25% |
| Current Ratio | 6.05% | 0% | 0% | 3.21% |
| Quick Ratio | 5.71% | 0% | 0% | 3.19% |
| Cash Position Ratio | 5.26% | 0% | 0% | 2.64% |
| Liquididy | 75% | 0% | 0% | 65% |
| Short-term ratios | PNT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -5.68% | 0% | 0% | 221.1% |
| Return on assets | -1.77% | 0% | 0% | -16.16% |
| Return on sales | -314.62% | 0% | 0% | -357% |
| Return on invested capital | -104.81% | 0% | 0% | -792.47% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 28.03% | 0% | 0% | 82.63% |
| Debt ratio change over time | -1.24% | 0% | 0% | -1.1% |
| Dept financing | 8% | 0% | 25% | 25% |
| Current Ratio | 6.05% | 0% | 0% | 3.21% |
| Quick Ratio | 5.71% | 0% | 0% | 3.19% |
| Cash Position Ratio | 5.26% | 0% | 0% | 2.64% |
| Liquididy | 75% | 0% | 0% | 40% |